Recalling what we thought we knew about recall periods: a qualitative descriptive study of how adults diagnosed with cancer use recall periods for patient-reported outcome items about physical function
Including a 7-day recall period improves recall consistency for patients when answering physical function PROM items, but there is still room for improvement. The inaccuracy of recall for PROMs in clinical trials influences the ability to calculate the change in treatment outcomes over time and may conceal or emphasize actual treatment effects.
Authors
- Alexy Hernandez (ORCID: https://orcid.org/0000-0002-6474-3001)
- Cara Arizmendi (ORCID: https://orcid.org/0000-0001-5608-7385)
- Bryce B. Reeve (ORCID: https://orcid.org/0000-0002-6709-8714)
- Courtney Rory Goodwin (ORCID: https://orcid.org/0000-0002-6540-2751)
- Theresa Coles (ORCID: https://orcid.org/0000-0003-2941-8999)
- Debra M. Henke
- Thomas W. LeBlanc (ORCID: https://orcid.org/0000-0002-0546-7895)
- Rebecca Fillipo (ORCID: https://orcid.org/0000-0003-1467-7971)
- Kate Plyler
- Sandhya Lagoo‐Deenadayalan
- Kevin P. Weinfurt
Institutions
- Duke University (US)
- AstraZeneca (United States) (US)
Publication Details
- Journal
- Quality of Life Research
- Published
- 2024-12-04
- DOI
- https://doi.org/10.1007/s11136-024-03847-1
- Citations
- 1
- Primary Topic
- Cancer survivorship and care
- Type
- article
- Field-Weighted Citation Impact
- 0.28
Funders
- U.S. Food and Drug Administration